🍄 Nation's First

Oregon has made history. Plus, a heated feud in Florida.

You're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Thursday Cannabis Investors: Cannabis companies about to release earnings reports, get your news here.

Plus, New York has closed more than 1,000 illegal cannabis stores, resulting in a 72% increase in legal cannabis sales. Discover how this crackdown is reshaping the market.

On The Go: Check out the newest episode of Cannabis Insider, also available on Apple and Spotify.

Puff Pass: Did someone forward you this email? Click here to get automatically subscribed.

TOP STORY

Briefly: A heated feud has erupted between Florida Governor Ron DeSantis and a prominent GOP stalwart over cannabis legalization, drawing significant attention from both sides of the political spectrum.

So: Adding fuel to the fire, Donald Trump and Florida's top law enforcement officials have also weighed in on the contentious issue.

What’s Next: What are the key points of contention, and how might this debate shape the future of cannabis policy in Florida?

Explore the intricacies of this political clash and its potential implications for the state's cannabis landscape. Read more to uncover the details of this unfolding story.

PRESENTED BY CANNABIS CAPITAL CONFERENCE

Join us on October 8th and 9th in Chicago for the world's largest gathering of cannabis investors - happening just ONE month before the Presidential election.

Get your tickets now by following this link, and access a 20% discount using the code JAVI20.

ZINGERS

November Election: Texas Town Becomes Third To Successfully Place Cannabis Decriminalization On November Ballot

Tilray CEO On Future Of Cannabis And Federal Rescheduling: 'We Did Not Sit Back And Wait'

Cannabis Regulation: RAW Rolling Papers Are Not 'Drug Paraphernalia,' Court Confirms

Ohio Cannabis: Ohio Approves 34 Dispensaries As Recreational Sales Near, New Cannabis DUI Testing Bill Controversy

Cannabis Stocks: Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 28% YoY Drop In Q3 Net Sales, Reaffirms 2024 Outlook

ONE MORE FOR THE ROAD

Briefly: Oregon has made history by granting the nation's first-ever psilocybin edibles manufacturer license, marking a groundbreaking step in the realm of psychedelic therapies.

Why It Matters: This pioneering move positions Oregon at the forefront of the emerging psilocybin industry, opening new avenues for mental health treatments.

What’s Next: What does this license entail, and who is leading this innovative venture? How might this development influence the future of psychedelic medicine and its acceptance across the U.S.?

Dive into the details of this historic milestone and explore the potential impacts on mental health care. Read more to stay informed about this exciting advancement in psilocybin therapy.

PRESENTED BY CANNABIS CAPITAL CONFERENCE

Join us on October 8th and 9th in Chicago for the world's largest gathering of cannabis investors - happening just ONE month before the Presidential election.

Get your tickets now by following this link, and access a 20% discount using the code JAVI20.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.